To join this case, fill out the form below
By clicking on the Submit button below, I acknowledge that I have read the Retainer Agreement and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
By clicking on the Submit button below, I acknowledge that I have read the Derivative Retention Letter and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
A signed Retainer Agreement will be sent to your email shortly.
Oops! Something went wrong while submitting the form.

Jernigan Capital, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Jernigan Capital, Inc. (“JCAP” or the “Company”) (NYSE: JCAP) in connection with the proposed acquisition of the Company by NexPoint Advisors, L.P.  Under the terms of the acquisition agreement, holders of the Company’s common stock will receive $17.30 in cash for each share that they own, while holders of the Company’s Series B Preferred stock will receive $25.00 per share in cash plus all accrued dividends.

WeissLaw is investigating whether JCAP’s board acted to maximize shareholder value in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of the proposed acquisition of the Company, and whether all information regarding the valuation of the deal will be fully and fairly disclosed to JCAP shareholders.  These issues are of particular concern given that Series B Preferred shareholders will receive nearly $7.00 more per share than common shareholders upon consummation of the proposed transaction.  Additionally, at least one analyst set a price target of $20.00 per JCAP share, or approximately $3.00 above the per-share merger price.\n\nWeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected].

Other Cases